Trial
NCT02137252
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Invasive Breast Cancer (Stage I-III)
Intervention
Naltrexone
Why stopped
no enough patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-16